NIIN Output Data
NIIN:
NSN:
Item Name:
MAGNESIUM SULFATE INJECTION , USP
Definition:
Reference/Part Number
Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
---|---|---|---|---|---|---|---|---|
NDC63323-0064-20 | 1DQP2 | A | 3 | 2 | 4 | ZZ | ||
A91B108 | 66732 | A | 5 | 1 | 4 | KX | ||
NDC00469-6400-40 | 60567 | A | 5 | 2 | 4 | ZZ |
CAGE Information
Code | Company |
---|---|
1DQP2 | AMERICAN PHARMACEUTICAL PARTNERS |
66732 | DEPARTMENT OF THE ARMY U S ARMY MEDI |
60567 | LYPHOMED INC DIV OF FUJISAWA USA INC |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
MRC | Requirements Statement | Clear Text Reply |
---|---|---|
SUPP | SUPPLEMENTARY FEATURES | MEDSEP ITEM FOR DOD,LYPHOMED |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 20.000 MILLILITERS |
CQCT | PRIMARY CONTAINER TYPE | VIAL |
AKJQ | PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 25 |
CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | MAGNESIUM SULFATE INJECTION USP 20 ML VIAL 25S |
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 50.000 PERCENTAGE, W/V MAGNESIUM SULFATE ACTIVE INGREDIENT |